BALAXI Pharmaceutical LTD is Showing Good Strength Can be Held
Company has a good return on equity (ROE) track record: 3 Years ROE 47.3%.
Debtor days have improved from 71.3 to 56.7 days.
Financial
Performance Commentary
6
Revenue
Higher contribution from the pharmaceuticals business led to y-o-y growth of 20% in revenues for FY23
compared to FY22. The sha